Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.21037/jgo-21-98
|View full text |Cite
|
Sign up to set email alerts
|

The expression and prognostic value of REXO4 in hepatocellular carcinoma

Abstract: Background: Globally, one of the dominant causes of cancer-related mortality is liver cancer. Identification of potent biomarkers for initial stage diagnosis and prognosis is a key factor to ensure efficient therapy and reduce the mortality rate in liver cancer patients. REXO4 has been reported in neuropathic pain and familial isolated pituitary adenoma (FIPA), however, its relationship with liver cancer is still elusive.Methods: In an attempt to scrutinize the expression of REXO4 in liver cancer, the Oncomine… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 26 publications
(37 reference statements)
1
2
0
Order By: Relevance
“…Among the lipolysis regulators uncovered in our screen, we found an enrichment for JUN/SMAD family members, which are growth-related proteins that have been linked to lipolytic suppression in adipocytes through lipase gene networks ( 8 , 9 , 42 ). Together with identifying several transcription factors that have been linked to adiposity or metabolic disease in other tissues [KLF2 ( 43 ), KLF7 ( 44 ), REXO4 ( 45 ), and TSC22D1 ( 46 )], these findings validate the utility of our human adipocyte screening platform as a resource of transcriptional regulators of adipocyte lipid mobilization. In this vein, we use protein network mapping to uncover a previously unknown role for histone chaperone proteins and mRNA elongation/splicing factors in regulating adipocyte lipolysis.…”
Section: Discussionsupporting
confidence: 58%
“…Among the lipolysis regulators uncovered in our screen, we found an enrichment for JUN/SMAD family members, which are growth-related proteins that have been linked to lipolytic suppression in adipocytes through lipase gene networks ( 8 , 9 , 42 ). Together with identifying several transcription factors that have been linked to adiposity or metabolic disease in other tissues [KLF2 ( 43 ), KLF7 ( 44 ), REXO4 ( 45 ), and TSC22D1 ( 46 )], these findings validate the utility of our human adipocyte screening platform as a resource of transcriptional regulators of adipocyte lipid mobilization. In this vein, we use protein network mapping to uncover a previously unknown role for histone chaperone proteins and mRNA elongation/splicing factors in regulating adipocyte lipolysis.…”
Section: Discussionsupporting
confidence: 58%
“…Unlike KDM5B , REXO4 is much less well-investigated in cancer biology. Current literature illustrates overexpression in hepatocellular carcinoma that is associated with tumor progression and immune infiltration [ 47 , 48 ]. Further investigations are needed to unravel the role of KDM5B and REXO4 loss in high-risk UM.…”
Section: Discussionmentioning
confidence: 99%
“…Elevated REXO4 expression is linked to unfavorable outcomes in HCC patients and may be connected to immune infiltration in liver cancer. A comprehensive understanding of the role of REXO4 could pave the way for targeted drug therapies and further exploration of its mechanisms in liver cancer carcinogenesis ( 9 ). In addition, PTER protein is significantly up-regulated in HCC tumors, and its high expression is associated with aggressive clinicopathological features, including advanced tumor staging, vascular invasion, recurrence, and shortened OS and disease-free survival (DFS) time.…”
Section: Introductionmentioning
confidence: 99%